INVN Holdings Information

INVN is an equity ETF with a total of 52 individual holdings. The top holdings are Enphase Energy stock at 2.84%, F5, Inc. at 2.55%, Merck & Co. at 2.53%, Organon & Co. at 2.46%, and Bristol-Myers Squibb Company at 2.46%.

Total Holdings

Top 10 Percentage

24.55%

Asset Class

Equity

ETF Category

Mid-Cap Blend

Assets

12.09M

PE Ratio

19.22

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ENPH	Enphase Energy, Inc.	2.84%	8,778
2	FFIV	F5, Inc.	2.55%	1,071
3	MRK	Merck & Co., Inc.	2.53%	2,523
4	OGN	Organon & Co.	2.46%	35,490
5	BMY	Bristol-Myers Squibb Company	2.46%	5,063
6	BMRN	BioMarin Pharmaceutical Inc.	2.37%	4,751
7	ILMN	Illumina, Inc.	2.37%	2,017
8	REGN	Regeneron Pharmaceuticals, Inc.	2.34%	356
9	GNTX	Gentex Corporation	2.33%	11,220
10	ZM	Zoom Communications, Inc.	2.32%	3,012
11	CRUS	Cirrus Logic, Inc.	2.28%	2,112
12	ALGN	Align Technology, Inc.	2.27%	1,666
13	PFE	Pfizer Inc.	2.25%	10,092
14	JAZZ	Jazz Pharmaceuticals plc	2.23%	1,545
15	INCY	Incyte Corporation	2.22%	2,542
16	ETSY	Etsy, Inc.	2.21%	4,792
17	BIIB	Biogen Inc.	2.19%	1,428
18	DOX	Amdocs Limited	2.18%	3,396
19	EXEL	Exelixis, Inc.	2.16%	5,864
20	OKTA	Okta, Inc.	2.13%	2,988
21	DLB	Dolby Laboratories, Inc.	2.06%	3,893
22	NBIX	Neurocrine Biosciences, Inc.	2.04%	1,697
23	CCC	CCC Intelligent Solutions Holdings Inc.	2.03%	34,130
24	DV	DoubleVerify Holdings, Inc.	2.02%	23,845
25	ZBRA	Zebra Technologies Corporation	2.01%	996

Showing 25 of 52 holdings

Subscribe to see the full list

Activate Now

As of Feb 2, 2026